DY
Dyadic International, Inc.
DYAI · NASDAQ
$0.52 -2.77% (-$0.01)
1M -47.74%
Market Cap $19.0M
P/E Ratio -
Div. Yield -
ROE 2,918.10%
Piotroski F-Score Weak
3/9Valuation
30 /100
Expensive P/S 5.46x
PEG N/A
P/E N/A
Growth
0 /100
Declining Book val. growth 51.92%
Rev. growth 25.08%
FCF growth N/A
Profitability
11 /100
Weak Op. margin 213.59%
Gross margin 30.44%
FCF margin 213.22%
Quality
7 /100
Poor ROA 116.60%
ROIC 278.95%
Asset turnover 0.53x
Debt
36 /100
Moderate Int. coverage -17.20x
Current ratio 1.65x
Debt/Assets N/A
Stability
42 /100
Moderate EPS volatility 22.87%
Beta 1.15x
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na DYAI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mark A. Emalfarb
Employees
5
Headquarters
Jupiter
Nadcházející události
11 LIS
Earnings
Upcoming earnings report